Sarasota company starting new drug trial

  • By Business Observer Staff
  • | 5:30 p.m. January 30, 2015
  • | 0 Free Articles Remaining!
  • Manatee-Sarasota
  • Share

SARASOTA — Rock Creek Pharmaceuticals Inc. (symbol: RCPI; recent price: 20 cents), a drug development company focused on chronic inflammatory disorders, announced that the United Kingdom's Medicines Healthcare Products Regulatory Agency has approved its clinical trial application.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news
Subscribe

Already subscribed? Sign in.

Latest News

  • February 7, 2026
Tampa airport unveils final design for new $1.5B airside terminal
  • February 7, 2026
Report: NY, Idaho among feeder states for Sarasota, Manatee growth
  • February 6, 2026
Southwest Florida homebuilder dies at 91
  • February 6, 2026
California dental insurer cutting Tampa jobs

Sponsored Content